Intravenous and oral antibiotics in respiratory tract infection: An international observational study of hospital practice

Pharmacy World and Science

Volumn 24, Issue 6, 2002, Pages 247-255

  Cooke, J ^a   Kubin, M ^b   Morris, T ^a   Ribas, J ^c   Kramer I ^d   Kammerer W ^e   Fornaini, R ^f   Ballet, A C ^g   Sagnier, P P ^h  

^a WITHINGTON HOSPITAL   (United Kingdom)

^b Health Economics and Outcomes Research   (Germany)

^c HOSPITAL CLÍNIC   (Spain)

^d JOHANNES GUTENBERG UNIVERSITY   (Germany)

^e DR HORST SCHMIDT KLINIKEN   (Germany)

^f CAREGGI UNIVERSITY HOSPITAL   (Italy)

^g BORDEAUX UNIVERSITY HOSPITAL   (France)

^h Bayer plc UK   (United Kingdom)

Author keywords

Antibiotics; Hospital pharmacy; Intravenous antibiotics; Observational study; Oral antibiotics; Respiratory tract infection; Switch therapy

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT;

ADOLESCENT; ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; FRANCE; GERMANY; HOSPITAL CARE; HUMAN; INTERNATIONAL COOPERATION; ITALY; MAJOR CLINICAL STUDY; MALE; NURSE; PHARMACIST; PHYSICIAN; PNEUMONIA; QUESTIONNAIRE; RESPIRATORY TRACT INFECTION; UNITED KINGDOM; AGED; CLINICAL TRIAL; HOSPITALIZATION; INTRAVENOUS DRUG ADMINISTRATION; METHODOLOGY; MIDDLE AGED; MULTICENTER STUDY; OBSERVATION; ORAL DRUG ADMINISTRATION; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; STATISTICS;

ADMINISTRATION, ORAL; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; FEMALE; HOSPITALIZATION; HUMANS; INFUSIONS, INTRAVENOUS; INTERNATIONALITY; MALE; MIDDLE AGED; OBSERVATION; PROSPECTIVE STUDIES; RESPIRATORY TRACT INFECTIONS;

EID: 0038652173     PISSN: 09281231     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1021522226178     Document Type: Article

References (22)

1. Mandell LA et al. Sequential antibiotic therapy: effective cost management and patient care. Can J Infect Diseases 1995;6:306-15.
2. Ramirez JA et al. Early switch from intravenous to oral cephalosporin in the treatment of hospitalized patients with community-acquired pneumonia. Arch Intern Med 1995;155:1273-6.
3. Frighetto L et al. Intravenous to oral stepdown program: four years of experience in a large teaching hospital. Ann Pharmacother 1992;26:1477-51.
4. Louie TJ. Intravenous to oral stepdown antibiotic therapy: another cost-effective strategy in an era of shrinking health care dollars. Can J Infect Diseases 1994; 5(Suppl C):45C-50C.
5. Parker SE, Davey PG. Pharmacoeconomics of intravenous drug administration. PharmacoEconomics 1992;1:103-15.
6. Francombe P. Intravenous filters and phlebitis. Nursing Times 1988;84:p. 34-5.
7. Ramirez JA et al. Early switch from intravenous to oral antibiotics and early hospital discharge. Arch Intern Med 1999;159:2449-54.
8. Ikeda A, Nishimura K, Izumi T. Pharmacological treatment in acute exacerbations of chronic obstructive pulmonary disease. Drugs Aging 1998;12:129-37.
9. Lorenz J. Comparison of 5-day and 10-day cefixime in the treatment of acute exacerbation of chronic bronchitis. Chemotherapy 1998;44:(Suppl 1):15-8.
10. DeAbate CA et al. Effectiveness of short course therapy (5 days) with grepafloxacin in the treatment of acute bacterial exacerbations of chronic bronchitis. Clin Ther 1999;21:172-88.
11. Ramirez JA. Advances in antibiotic use: switch therapy. Curr Ther Res Clin Exp 1994;55(suppl A): 30-4.
12. Allen B. A campaign to improve the timing of conversion from intravenous to oral administration of antibiotics. Aust J Hosp Pharm 1992;22:434-9.
13. Laing RBS et al. The effect of intravenous-to-oral switch guidelines in the use of parenteral antimicrobials in medical wards. J Antimicrob Chemother 1998;42:107-11.
14. Al-Eidan FA et al. Use of a treatment protocol in the management of community acquired lower respiratory tract infection. J Antimicrob Chemother 2000;45:387-94.
15. Halls GA. The management of infections and antibiotic therapy: a European survey. J Antimicrob Chemother 1993;31: 985-1000.
16. Vogel F. Sequential therapy in the hospital management of lower respiratory infections. Am J Med 1995; 99(Suppl 6B): 14S-19S.
17. Zamin MT. Pitre MM, Conly JM. Development of an intravenous-to-oral route conversion program for antimicrobial therapy at a Canadian tertiary care health facility. Ann Pharmacother 1997;31:564-70.
18. Cunha BA. Community-acquired pneumonia. Cost-effective antimicrobial therapy. Postgraduate Med 1996;99:109-19.
19. Ahkee S et al. Early switch from intravenous to oral antibiotics in hospitalized patients with infections: a 6-month prospective study. Pharmacotherapy 1997;17:569-75.
20. Jensen KM, Paladino JA. Cost-effectiveness of abbreviating the duration of IV antibacterial therapy with oral fluoroquinolones. Pharmacoeconomics 1997;11:64-74.
21. Janknegt R, van der Meer JWM. Antimicrobial practice. Sequential therapy with intravenous and oral cephalosporins. J Antimicrob Chemother 1994;33:169-77.
22. Sevinc F et al. Early switch from intravenous to oral antibiotics: guidelines and implementation in a large teaching hospital. J Antimicrob Chemother 1999;43:601-6.